Targeted therapy Archives

Filter by
Categories
Tags
Authors
Show all

All
Active Clinical Trials
From the Co-Chairs
Institution Spotlights
News in Brief
People
Special Topics
Trial Results

All
AACR
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia
Acute myeloid leukemia (AML)
Acute promyelocytic leukemia
Adolescents and young adults
Advanced melanoma
Advanced practice providers
Advocacy
Anal cancer
ARPA-H
ASCO
Awards
AYA cancer
B-cell lymphoma
Big data
Biostatistics
Bladder cancer
Blood cancer
Blood cancers
Brain cancer
Breast cancer
Cancer
Cancer care delivery research
Cancer control
Cancer research
Cancer research policy
Cancer screening
Cancer surveillance
Cardiotoxicity
CBPF
Chemoimmunotherapy
Chemotherapy
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic myeloid leukemia
Clinical trial
Clinical trials
Colorectal cancer
Colorectal liver metastases
ComboMATCH
Comis Symposium
Communication
Community oncology
Cooperative Group cancer research
Correlative science
COVID-19
CT scans
Data science
DCIS
De-escalation
Deep learning
DEI
Developmental therapeutics
Diversity
EGFR
Engineering
Esophagus cancer
Ethics
Federally-funded cancer research
Financial hardship
Gallbladder cancer
Gastric cancer
Gastroesophageal junction cancer
GBM
Gender equity
Genetic testing
Genomics
Geriatric oncology
GI cancer
Glioblastoma
GM-CSF
Green tea catechins
Group Meeting
GU cancer
Head and neck cancer
Head and neck squamous cell carcinoma
health care
Health care administration
Health equity
Hematology
Hepatic arterial infusion
HER2-positive breast cancer
Hormone therapy
Imaging
Immune checkpoint inhibitors
Immunotherapy
In memory
Institution Evaluation
Just-in-time clinical trials
Kidney cancer
Language
Leadership
Leukemia
Liver cancer
Lung cancer
Lung inflammation
Lymphoblastic lymphoma
Lymphoma
Mammography
Meetings
Melanoma
Mentorship
Mesothelioma
Misinformation
Multiple myeloma
Myelodysplastic neoplasms
Myelodysplastic syndromes
Myeloid malignancies
Myeloma
myeloMATCH
National Cancer Act
Natural language processing
NCI
NCI-Designated Comprehensive Cancer Centers
NCI-MATCH
NCORP
NCTN Grant
Neuroendocrine tumors
Non-Hodgkin lymphoma
Non-small cell lung cancer
NSCLC
Older adults
Ovarian cancer
Pancreatic cancer
Pancreatic cyst
Pancreatic cysts
Pancreatic NETs
Pathology
Patient registry
Patient-reported outcomes
Penile cancer
Peripheral neuropathy
Personalized medicine
Personalized screening
Pneumonitis
Policy
Pragmatic clinical trials
Precision medicine
Prevention
Prostate cancer
Proteasome inhibitors
Public-private partnerships
Racism
Radiation
Radiology
Rare disease
Real-world data
Recurrence
Renal cell
Renal cell carcinoma
Reproductive health
Research results
Retroperitoneal sarcoma
Sarcoma
Scholarship
Sexuality
Side effects
Smoking cessation
Smoldering multiple myeloma
Social determinants of health
Social genomics
Stomach cancer
Survivorship
Symptom control
Symptom management
Symptom science
Targeted therapy
Throat cancer
Thyroid cancer
TMIST
Tobacco cessation
Translational research
Urinary tract cancer
Vaccination
Women in oncology
Young investigators

All
Diane Dragaud
ECOG-ACRIN Staff
ECOG-ACRIN Staff

May 28, 2021

Doctor and patient reviewing test results

May 28, 2021

Now Enrolling: EA2192/APOLLO for Pancreatic Cancer

This phase II study, led by Dr. Kim Reiss Binder, is exploring whether the addition of maintenance PARP inhibition for BRCA- or PALB2-mutated pancreatic cancer improves outcomes

March 31, 2021

March 31, 2021

Now Enrolling: EA6194 for Operable Melanoma

This phase II study, led by Dr. Ahmad Tarhini, is testing neoadjuvant treatment with pembrolizumab alone versus pembrolizumab and an investigational drug called CMP-001

January 14, 2020

Institution Spotlight: Fox Chase Cancer Center

A Standing Main Member of ECOG-ACRIN since 1971